Home/Filings/8-K/0001683168-26-000097
8-K//Current report

NOCERA, INC. 8-K

Accession 0001683168-26-000097

$NCRACIK 0001756180operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:30 PM ET

Size

195.9 KB

Accession

0001683168-26-000097

Research Summary

AI-generated summary of this filing

Updated

Nocera, Inc. Completes Meixin Sale and Acquires 35% of LONGWOOL

What Happened

  • Nocera, Inc. announced it completed two transactions on January 1, 2026. The company closed the sale of 80% of its variable interest entity equity interests in Meixin Institutional Food Development Co., Ltd. to Yinuo Investment Consulting Co., Limited for $420,000.
  • On the same date, Nocera completed the purchase of 35% of the outstanding equity of LONGWOOL (a French société par actions simplifiée) for $400,000. Both agreements were originally entered into on December 1, 2025 and were previously disclosed in the company’s December 2025 8-K filings.

Key Details

  • Sale: 80% of Meixin VIE equity transferred to Yinuo Investment; purchase price received $420,000; closing date Jan 1, 2026.
  • Purchase: 35% equity stake in LONGWOOL acquired for $400,000; closing date Jan 1, 2026.
  • Net cash effect at closing: Nocera received $420,000 and paid $400,000 (net +$20,000).
  • Transactions were reported under Item 2.01 (Completion of Acquisition or Disposition of Assets) of the Form 8-K.

Why It Matters

  • The Meixin disposition reduces Nocera’s ownership/exposure in that Taiwan-based food processing and catering business (now retaining 20% of the VIE interest), and provides immediate cash proceeds of $420,000.
  • The LONGWOOL purchase creates a new minority equity investment (35%) in a French company, representing a strategic ownership stake and potential future influence or returns tied to LONGWOOL’s business.
  • For investors, these transactions change the company’s asset and investment mix and had a small positive net cash impact at closing (+$20,000). The 8-K does not provide additional financial results or forward-looking guidance related to how these deals will affect revenue or earnings.